Protecting against future shock--inhalational anthrax.
Nabel
Gary J
GJ
D000818:Animals; D000881:Anthrax / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D023482:Bioterrorism / Q000517:prevention & control; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C542124:raxibacumab